- October 29, 2020
Canada | A final order adding Mitotane to Schedule 1 of CEPA 1999 was published
In October 2017, the final screening assessments for 3 substances in this batch (CAS RNs 53-19-0, 515-03-7 and 13080-86-9) were released and the related notices were published in the Canada Gazette, Part I: Vol. 151, No. 43 - October 28, 2017. The final assessments concluded that 1 substance in this batch, mitotane, meets one or more criteria in section 64 of CEPA 1999. The Government has added this substance to Schedule 1 of the Act. A proposed risk management approach for mitotane was also released on this date for a 60-day public comment period.
CONTINUE READING ON: canada.ca